Navigation Links
Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth
Date:4/8/2009

ment of patients with non-Hodgkin's lymphoma. Micromet's second BiTE antibody in clinical development is MT110, which targets the epithelial cell adhesion molecule (EpCAM). The Company owns all rights to MT110, which is currently in a phase 1 clinical trial for the treatment of patients with solid tumors. The Company's third clinical stage antibody is adecatumumab, also known as MT201, a traditional human monoclonal antibody that targets EpCAM-expressing solid tumors. Micromet is developing adecatumumab in collaboration with Merck Serono in a phase 1b clinical trial evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. Micromet licensed a fourth clinical stage antibody, MT293, to TRACON Pharmaceuticals, Inc. MT293 is being developed in a phase 1 clinical trial for the treatment of patients with cancer. The Company's preclinical programs include MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, psoriasis, or multiple sclerosis. Micromet has granted an exclusive option to Bayer Schering Pharma AG to license a BiTE antibody against an undisclosed solid tumor target. Additional BiTE antibodies, targeting CEA, CD33, Her2, EGFR and MCSP, respectively, are in different stages of preclinical development.

Forward-Looking Statements

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking statements include statements regarding the efficacy and intended utilization of our product candidates and the developme
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
2. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
3. EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference
4. Genmab Announces HuMax-CD32b Pre-Clinical Program
5. Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination
6. Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity
7. Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds
8. CorMatrix Announces Pre-Clinical Data Suggesting Next Generation ECM Technology(TM) Can Improve Cardiac Function
9. Michael J. Fox Foundation Commits Up To $5 Million for Pre-Clinical Drug Development Under Industry-Exclusive Therapeutics Development Initiative
10. Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-101 Repositioned Drug for Multiple Sclerosis
11. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Rancho BioSciences ... integration of Omicsoft’s Array Suite with tranSMART . ... be able to send data in tranSMART to Array ... all versions of tranSMART including the new 1.2 release. ... visualization and storage for the analysis of high dimensional ...
(Date:7/31/2014)... July 31, 2014 “Rapid technological ... across the U.S., increasing unemployment, depressing American consumer ... It is a Catch 22—we need automated manufacturing ... means fewer jobs,” says economist and corporate relocation ... Corporate Top 10 Pro-Business States for 2014, co-published ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The Kidney Cancer ... of its monthly news magazine, Kidney Cancer News. , ... presence on a website maintained by an international news organization. ... immediate increase in viewers.” , This month’s program highlights news ... tumors analyzed in a recent study. Kidney Cancer News ...
(Date:7/30/2014)... , July 30, 2014 Regulus ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended June ... U.S. financial markets close. Regulus will ... 6, 2014, at 5:00 pm Eastern Daylight Time to ...
Breaking Biology Technology:Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 2Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3
... May 15 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio-,Pharmaceutical Technology, ... and producer of plant extracts and pharmaceutical ... food production, today,announced that there was no ... result,of the Sichuan Earthquake., Immediately following ...
... initiative will provide insights to ICD and CRT-D ... ... Boston Scientific,Corporation (NYSE: BSX ) today announced a new clinical ... The initiative will use the substantial LATITUDE data to,seek answers to ...
... Md., May 15 Human Genome Sciences,Inc. (Nasdaq: ... McRaith has joined the,Company as Vice President, Hepatology ... - Hematology, Genentech Corporation, will,report to Barry A. ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO ), "Kevin McRaith ...
Cached Biology Technology:Huifeng Bio-Pharmaceutical (HFGB) Announces No Earthquake Related Damage to Facilities 2Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data 2Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data 3Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data 4Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise 2Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise 3
(Date:7/31/2014)... completed a 20-year study that looks at the ... times of the year. It finds that burning ... has no measurable negative consequences for the prairie ... The study was conducted by Gene Towne, research ... chief, and Joseph Craine, research assistant professor, both ...
(Date:7/31/2014)... noise alters how the brain processes speech, potentially ... to neuroscientists at The University of Texas at ... in Ear and Hearing , researchers demonstrated ... affects the brain,s recognition of speech sounds. , ... the population, affecting an estimated 15 percent of ...
(Date:7/31/2014)... Dr. Oren Tessler, Assistant Professor of Clinical Surgery ... Medicine, is part of a team of plastic and ... a method to screen and select patients for a ... the patients who underwent this surgery to decompress the ... a bonus cosmetic eyelid surgery. The study, which confirms ...
Breaking Biology News(10 mins):Study finds benefits to burning Flint Hills prairie in fall and winter 2Study finds benefits to burning Flint Hills prairie in fall and winter 3UT Dallas study reveals effect of loud noises on brain 2Surgeons report significant migraine relief from cosmetic eyelid surgery technique 2
... College of Medicine have discovered how the mutated huntingtin gene ... Huntington,s disease. The report of their findings is available in ... to show that the mutated huntingtin gene activates a particular ... further, to show what effect activation of that enzyme has ...
... DC - A protein known to play a role ... have a mixed function in breast cancer development, say ... University Medical Center (GUMC). The findings, presented at ... DC, indicate that the function of this protein, known ...
... Sophisticated sensors that measure leaf wetness, soil moisture ... Springbrook World Heritage precinct in south-east Queensland. ... uncover the microclimatic conditions favourable for rapid natural ... of ten sensor nodes, connected wirelessly, has been ...
Cached Biology News:Huntington's disease deciphered 2Huntington's disease deciphered 3Dual role in breast tissue for a protein involved in leukemia 2Rainforest rehab in every sense 2
... end-users to be "a delight to use" ... microscopy and electronic imaging. With its ergonomic ... require much space and can easily be ... DM-BA300 combines Motic's own revolutionary Colour Corrected ...
lid holder -see Blotters (Semi-Dry) for more info...
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human CD69 TAC is designed to deplete human CD69 from samples to isolate resting CD4+ or CD8+ T cells....
... Aquarius 384 is a compact and ... head is a unique flow-through device, ... the included wash system. Optional ... stacker system. Will be upgradable ...
Biology Products: